| Product name | Cell Counting Kit-8 (CCK-8) |
| Applications notes | Cell Counting Kit-8 (CCK-8) is designed to detect cell proliferation and cell toxicity based on WST-8 is reduced by dehydrogenases in cells to give an orange colored product (formazan). The amount of the formazan in cells is directly proportional to the number of living cells. |
| Alternative | CCK-8; WST-8; CCK8; WST8 |
| Formulation | Liquid solution |
| Kit components | • CCK-8 solution |
| Features & Benefits | • One-bottle, ready-to-use solution. • The product (formazan) produced by WST-8 is water soluble, No organic solvents or isotopes required. And the formazan is stable and safe. • The detection sensitivity using CCK-8 is higher than assays using other tetrazolium salts such as MTT, XTT, MTS or WST-1. • The same cells can be used for other cell assays because of the low toxicity of CCK-8. |
| Usage notes | • Since the CCK-8 assay is based on the dehydrogenase activity detection in viable cells, conditions or chemicals that affect dehydrogenase activity in viable cells may cause discrepancy between the actual viable cell number and the cell number determined using the CCK-8 assay. • Be careful not to introduce bubbles to the wells, since they interfere with the OD reading. • The incubation time varies by the type and number of cells in a well. Generally, leukocytes give weak coloration, thus a long incubation time (up to 4 hours) or a large number of cells (~105 cells/well) may be necessary. • If the color or PH of culture media is changed due to long-time culture, please change the culture media when adding CCK-8. • The same cells can be used for other cell assays because of the low toxicity of CCK-8. |
| Storage instructions | CCK-8 is stable for one year at 0-5°C with protection from light. Store it at -20°C for longer storage. Repeated thawing and freezing causes an increase in the background, which interferes with the assay. Please store the kit at 0-5°C for frequent use. |
| Shipping | Gel pack with blue ice. |
| Precautions | The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product. |
| Background | Cell Counting Kit-8 (CCK-8) allows very convenient assays by utilizing highly water-soluble tetrazolium salt-WST-8.[2-(2- methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt] produces a water-soluble formazan dye upon reduction in the presence of an electron mediator. CCK-8, being nonradioactive, allows sensitive colorimetric assays for the determination of the number of viable cells in cell proliferation and cytotoxicity assays. WST-8 is reduced by dehydrogenases in cells to give an orange colored product (formazan), which is soluble in the tissue culture medium. The amount of the formazan dye generated by dehydrogenases in cells is directly proportional to the number of living cells. The product (formazan) produced by WST-8 is water soluble, no organic solvents or isotopes required. And the formazan is stable and safe. The detection sensitivity using CCK-8 is higher than assays using other tetrazolium salts such as MTT, XTT, MTS or WST-1. |
| Alternative | CCK-8; WST-8; CCK8; WST8 |
Fig. Abbkine Economical Cell Counting Kit-8 (CCK-8) is designed to detect cell proliferation and cell toxicity.
Author：Park, Se-Ra, et al. Publication name：Biomaterials Research IF：11.3
Author：Lee G H, Park S H, Song B M, et al. Publication name：Journal of Hospital Infection IF：8.944
Author：Zou, Hailin, et al. Publication name：Cellular and Molecular Life Sciences IF：8
Author：Li F, Wang Y, Xu M, Hu N, Miao J, Zhao Y, Wang L. Publication name：Ecotoxicology and Environmental Safety IF：7.129
Author：Y Cao, P Cheng, S Sang, C Xiang, Y An Publication name：Regenerative Biomaterials IF：6.535
Author：O Juntit, K Sornsuwan, T Wisitponchai Publication name：International journal of molecular sciences IF：6.208
Author： Jiang Y, Zhang X, Wei T, Publication name：Frontiers in Cardiovascular Medicine IF：5.846
Author：X Ding, D Bian, W Li Publication name：Amino Acids IF：5.8
Author：X Wang, H Du, X Li Publication name：International Immunopharmacology IF：5.714
Author：Y Wen, X Zhang, L Wei, M Wu, Y Cheng Publication name：Frontiers in Pharmacology IF：5.6
Author： Shi X, Gu Y, Wan C Publication name：Frontiers in Chemistry IF：5.545
Author：Wu, Meizhu, et al. Publication name：Journal of Ethnopharmacology IF：5.4
Author：X Wu, Y Li, X Chen, Z Zhou, J Pang, X Luo Publication name：Journal of Materials Chemistry B, 2019. IF：5.047
Author：M Liu, Q Liu, Y Pei, M Gong, X Cui, J Pan Publication name：Arteriosclerosis, Thrombosis, and Vascular Biology, 2019. IF：4.65
Author： Tang L, Yu J, Zhuge S Publication name：TOXICOLOGY IF：4.571
Author：Liu L, Chen Y, Lin X, Wu M, Li J, Xie Q, Sferra TJ, Han Y, Liu H, Cao L, Yao M, Peng J, Shen A Publication name：Cancer Cell Int IF：4.175
Author：Shiwei Liu, Shanyu Gao, Tongming Liu Publication name：Cell Cycle IF：3.823
Author：Guo, Zhi, et al. Publication name：Pharmaceutical Biology IF：3.8
Author：Shiwei Yang, Shanyu Gao, Tongming Liu Publication name：Cell Cycle IF：3.699
Author：Li J, Liu L Publication name：Oncol Rep IF：3.417
Author：Zhang, Tieyuan, et al. Publication name：Neuroscience IF：3.3
Author：Ding X, Bian D, Li W, Xie Y, Li X, Lv J, Tang R, Publication name：Amino Acids IF：3.063
Author：W Fu, S Liu, J Jiao, Z Xie, X Huang, Y Lu, H Liu, S Hu Publication name：Materials (Basel) IF：3.057
Author：MI Boguś, AK Wrońska Publication name：Plos one IF：2.942
Author：Lv M, Zhang S, Dong Y, Cao L, Guo S Publication name：Cancer Manag Res IF：2.886
Author：Boguś MI, Wrońska AK, Kaczmarek A, Boguś-Sobocińska M Publication name：PLoS One IF：2.74
Author：AT OZDEMIR, C KIRMAZ Publication name：Asthma Allergy Immunol IF：2.732
Author：Ze-tai Wang, Yan Peng, Dan-dan Lou, Si-ying Zeng, Yuan-chao Zhu, Ai-wu Li, Ying Lyu, Dao-qi Zhu & Qin Fan Publication name：Chinese Journal of Integrative Medicine IF：2.626
Author：Pan YQ, Niu M, Liu SM, Bao YX, Yang K, Ma XB, He L, Li YX, Cao JX, Zhang X, Du Y Publication name：Int J Med Sci IF：2.523
Author：B Kavakcıoğlu Yardımcı, Z Mollaoğlu Publication name：Preparative Biochemistry & Biotechnology IF：2.3
Author：Yan Li, Zhenwei Jia, Hongbo Zhao Publication name：J Oncol IF：2.206
Author： Lv, S Zhang, Y Dong Publication name：Cancer Management and Research IF：1.8
Author：H Wihadmadyatami, S Karnati, S Ergún Publication name：f1000research IF：0.939
Author：Kustiati U, Ergün S, Karnati S, et al. Publication name：Scientia Pharmaceutica IF：/
Author：Yaprak Donmez Cakl，Zeynep Gunes Ozunal，Damla Gokceoglu Kayal，Ranan Gulhan Aktas Publication name： IF：
Author：D Lim, S Bae, T Oh Publication name：Journal of Veterinary Clinics IF：
Author：ERZURUMLU, Yalçın, Deniz Catakli, and Hatice Kübra DOĞAN. Publication name：Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi IF：
Author： Publication name： IF：
Author：X Zhang, J Li, M Wu, J Wu, S He, Y Lu, Q Ding, Y Wen Publication name：researchsquare IF：
You must be logged in to post a review.
Reviews
There are no reviews yet.